JUN 06, 2018 5:54 AM PDT

Computer Simulations Offer Alternative Methods for Diabetic Drugs

WRITTEN BY: Nouran Amin

The Governor's Chair for Molecular Biophysics at the University of Tennessee (Knoxville), Jeremy Smith, and the director for the Center for Molecular Biophysics at Oak Ridge National Laboratory, has collaborated with a research team from UT Health Science Center to find a chemical substance that may lower glucose levels in the same efficacy as the common diabetic metformin but with the possibility of being administered in lower dose.

Smith, in collaboration with Jerome Baudry, of the University of Alabama (Huntsville) as well as graduate student Karan Kapoor, from the University of Illinois at Urbana-Champaign, studied high-performance computing to develop sophisticated simulations that suggest chemicals that could activate GPRC6A, which is protein that regulates sugar levels while at the same time corrects abnormalities in pancreatic insulin secretion, glucose uptake into skeletal muscle, and the regulation of glucose and fat metabolism in the liver.

"This chemical compound lowers sugar levels in mice as effectively as metformin, but with a 30-times lower dose," Smith said. "It therefore is a good starting point for the development of a new and effective drug to fight diabetes."

Wolrdwide, about 400 million people suffer from Type 2 diabetes. The global cost of treatment and management of this metabolic disorder is estimated to be a trillion dollars annually. Metformin, a common diabetic drug that works to reduce the liver's production of sugar and lessen the risk of mortality, is currently first-line medication treatment by physicians. However, there remains a dire need for an alternative treatment option for patients who do not respond to metformin as well as others.

 

The computations derived from the research study confirmed that multiple chemical compounds, tested each by the Quarles laboratory at UTHSC, may activate the GPRC6A protein. Furthermore, a team of UTHSC medicinal investigators utilized the results from the research study to synthesize related molecules for pre-clinical testing use. The chemical compound by the name of ‘DJ-V-159’ was identified and concluded to be highly potent in inducing insulin secretion and decreasing glucose levels in mouse models.

 

Source: University of Tennessee at Knoxville

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 24, 2020
Immunology
Injectable Drug Stops HIV From Entering Cells
AUG 24, 2020
Injectable Drug Stops HIV From Entering Cells
Once in the body, HIV tracks down T cells that bear the CD4 receptor. It attaches to these immune cells, fusing itself w ...
AUG 12, 2020
Drug Discovery & Development
Fast Tracking Drug Therapies
AUG 12, 2020
Fast Tracking Drug Therapies
Fast-tracking drugs in a safe and effective way can eventually save the lives of many from life-threatening diseases. Ne ...
SEP 08, 2020
Drug Discovery & Development
New Drug Boosts Bone Growth in Children with Dwarfism
SEP 08, 2020
New Drug Boosts Bone Growth in Children with Dwarfism
A Phase III global clinical trial by the Murdoch Children’s Research Institute (MCRI) has found that a new drug, k ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 20, 2020
Cannabis Sciences
Should Cannabis Doses Be Standardized?
OCT 20, 2020
Should Cannabis Doses Be Standardized?
Should cannabis and its compounds such as tetrahydrocannabinol (THC), the psychoactive compound in cannabis, come in sta ...
OCT 21, 2020
Drug Discovery & Development
New ALS Treatment Extends Life for Several Months
OCT 21, 2020
New ALS Treatment Extends Life for Several Months
Currently, there are only two approved medications to treat Lou Gehrig's disease (also known as ALS), a condition po ...
Loading Comments...